Circulating tumor cells may predict prognosis
Circulating tumor cells may predict prognosis in early breast cancer
A study published in the June 2012 issue of Lancet Oncology reports early stage breast cancer patients who produce circulating tumor cells (CTC) may be at greater risk for breast cancer recurrence. Until now, lymph node biopsy has been the best predictor of prognosis. More research is needed to learn how to apply this new discovery.
Guests: Anthony Lucci, M.D. and Isabelle Bedrosian, M.D.